Medicine
Valsartan 4 mg/mL oral solution
Valsartan 4 mg/mL oral solution is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20℃-25℃ (68 °F-77 °F), excursions permitted to 15℃ -30℃ (59 °F -86 °F).
Key facts
- Active ingredient (INN)
- Valsartan
- Brand
- Sold under the generic name
- Strength
- 4 mg/mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 473 mL, 120 mL, 20 mL and 7 more
- Manufacturers
- AptaPharmaAdvagen PharmaANI PharmaceuticalsLifsa Drugs
- Origin register
- US FDA, United States
- Storage
- Store at 20℃-25℃ (68 °F-77 °F), excursions permitted to 15℃ -30℃ (59 °F -86 °F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09CA03 Valsartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 November 2021
- Identifiers
- RxCUI 1996254DailyMed set ID 508c5de8-9c70-57f5-e063-6394a90af295, 959b6790-feb7-45a9-9ea4-0ee1a7fce048, 47137b1a-f2b0-49af-99f0-6fb4f5a16578 +1NDC 76281-155, 70954-310, 72888-184 +1Application NDA209139, ANDA214102, ANDA216460
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 473 mL in 1 bottle | 72888-184-13 | Advagen Pharma | 5 June 2025 |
| 120 mL in 1 bottle | 72888-184-48 | Advagen Pharma | 5 June 2025 |
| 120 mL in 1 bottle, plastic | 70954-310-10 | ANI Pharmaceuticals | 2 November 2021 |
| 473 mL in 1 bottle, plastic | 70954-310-20 | ANI Pharmaceuticals | 2 November 2021 |
| 20 mL in 1 cup, unit-dose | 76281-155-56 | AptaPharma | 5 May 2026 |
| 120 mL in 1 bottle | 76281-155-64 | AptaPharma | 5 May 2026 |
| 473 mL in 1 bottle | 76281-155-82 | AptaPharma | 5 May 2026 |
| 10 cup, unit-dose in 1 tray / 20 mL in 1 cup, unit-dose | 76281-155-99 | AptaPharma | 5 May 2026 |
| 120 mL in 1 bottle, plastic | 72336-910-79 | Lifsa Drugs | 4 April 2022 |
| 473 mL in 1 bottle, plastic | 72336-910-89 | Lifsa Drugs | 4 April 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 December 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Valsartan
Clinical summary
Valsartan is an angiotensin 2 receptor blocker indicated for hypertension, to lower blood pressure in adults and children 1 year and older, among other approved uses. It is available as tablets and oral solution. MedsAcross supplies Valsartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ValsartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Diovan prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Valsartan 4 mg/mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.